K-numberK241989
Device nameCercare Medical Neurosuite (CMN) Capillary Function with Virtual Expert
ApplicantCercare Medical A/S
Product codeLLZ
Device classClass II
Decision dateDec 6, 2024
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

CMN Capillary Function with Virtual Expert is medical image processing software for trained professionals that analyzes CT and MRI brain imaging data. It visualizes tissue perfusion, diffusion, and blood volume parameters to help assess hemodynamic status in acute stroke and other conditions with compromised blood flow. The software runs on standard computers or virtual platforms and processes DICOM-compliant imaging data.

Technological characteristics

The subject device is identical to the predicate device (K230016) except for the addition of CT perfusion post-processing capability. Both devices use DICOM-compliant image acquisition and processing, support standard off-the-shelf computing platforms, and generate hemodynamic parameter maps (rCBF, rCBV, MTT, Tmax, ADC). The CT capability mirrors similar functionality in the reference device (RAPID, K182130).

Test standards cited

ISO 13485:2016 (quality management), ISO 14971:2019 (risk management), IEC 62304:2015 (software lifecycle), IEC 62366-1:2015 (usability engineering), NEMA PS 3.1-3.20:2016 (DICOM standard), and FDA guidance on cybersecurity in medical devices and computer-assisted detection devices.

Substantial equivalence argument

The subject device has identical intended use, indications, and technological principles to the predicate device K230016, differing only by adding CT perfusion post-processing. Performance validation testing using digital phantoms and retrospective clinical data demonstrated the subject device produces accurate hemodynamic parameters comparable to both the predicate and reference devices. Since both MRI functionality is identical to the predicate and CT functionality mirrors the cleared reference device (K182130) using similar algorithms, and no new safety or effectiveness concerns arise from the CT addition, substantial equivalence is established.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →